Inhibitory effect of danazol on melanogenesis in mouse B16 melanoma cells
Danazol inhibits melanogenesis in B16 melanoma cells by reducing tyrosinase protein levels through post-transcriptional regulation, without affecting tyrosinase mRNA or direct enzyme activity.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper screened more than 200 generic drugs for activity as potential skin-lightening agents using mouse B16 melanoma cells and found danazol inhibited melanogenesis in a dose-dependent manner (IC50 9.3 μM). The study showed danazol reduced cellular tyrosinase activity in B16 cells, while not directly inhibiting murine tyrosinase activity in a cell-free system. Western blotting indicated danazol downregulated tyrosinase protein levels, whereas RT-PCR showed it did not reduce tyrosinase mRNA, suggesting post-transcriptional regulation. The paper’s limitation is that its mechanistic evidence is confined to an in vitro melanoma cell model. Relevance to endometriosis: the references cite prior danazol treatment for pelvic endometriosis, though the paper itself focuses on melanogenesis inhibition in B16 melanoma cells.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
4,471 characters
· extracted from
oa-doi-fallback
· 2 sections
· click to expand
Abstract
References
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (1)
- Danazol 2022
References (18)
- Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis via openalex
- doi:10.1034/j.1600-0749.2003.00019.x via openalex
- doi:10.1152/physrev.00044.2003 via openalex
- doi:10.1038/jidsymp.2008.8 via openalex
- doi:10.1248/bpb.31.33 via openalex
- doi:10.1210/en.2008-1212 via openalex
- doi:10.1126/science.88.2290.481 via openalex
- doi:10.3390/ijms10093811 via openalex
- doi:10.1111/j.1600-0749.2003.00126.x via openalex
- doi:10.1111/j.1600-0749.2006.00334.x via openalex
- doi:10.3390/ijms10062440 via openalex
- W1802200939 via openalex
- W2140182333 via openalex
- W2145052058 via openalex
- doi:10.3390/ijms10104257 via openalex
- doi:10.1111/j.1468-2494.2010.00619_1.x via openalex
- doi:10.1038/sj.jid.5700683 via openalex
- doi:10.1248/bpb.27.806 via openalex
Cited by (1)
- Danazol 2022
Source provenance
- openalex
- last seen: 2026-05-11T06:12:37.668444+00:00